AI
Tuesday, December 03, 2024 5:08:01 PM
The company and Liau knew about pspd from well before the trial started. There's a reason for the info arm (which nobody has heard about in 8 years).
All you need to know about the Jama paper. (courtesy of Jammy James). Remove those who did not get treatment (the control arm) and the mOS goes down. If you had any brain cells you'd realize that's bad for the patients, bad for the trial, and bad for stock. The top thin line, for the brain challenged, is the blended data which include those who never even touched DCVax.
No amount of bread-crumbing makes the data not suck.
All you need to know about the Jama paper. (courtesy of Jammy James). Remove those who did not get treatment (the control arm) and the mOS goes down. If you had any brain cells you'd realize that's bad for the patients, bad for the trial, and bad for stock. The top thin line, for the brain challenged, is the blended data which include those who never even touched DCVax.
No amount of bread-crumbing makes the data not suck.
